Amneal Pharmaceuticals Inc (AMRX)
8.19
-0.16
(-1.92%)
USD |
NASDAQ |
Sep 27, 16:00
8.19
0.00 (0.00%)
After-Hours: 20:00
Amneal Pharmaceuticals Cash from Operations (Quarterly): 39.66M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 39.66M |
| March 31, 2024 | -4.41M |
| December 31, 2023 | 135.82M |
| September 30, 2023 | 81.39M |
| June 30, 2023 | -11.34M |
| March 31, 2023 | 139.71M |
| December 31, 2022 | -23.29M |
| September 30, 2022 | 93.57M |
| June 30, 2022 | -125.52M |
| March 31, 2022 | 120.34M |
| December 31, 2021 | 63.26M |
| September 30, 2021 | 82.36M |
| June 30, 2021 | -51.93M |
| Date | Value |
|---|---|
| March 31, 2021 | 148.13M |
| December 31, 2020 | 105.96M |
| September 30, 2020 | 44.78M |
| June 30, 2020 | 179.24M |
| March 31, 2020 | 49.03M |
| December 31, 2019 | -50.89M |
| September 30, 2019 | 139.91M |
| June 30, 2019 | 21.09M |
| March 31, 2019 | -108.41M |
| December 31, 2018 | 259.65M |
| September 30, 2018 | 62.13M |
| June 30, 2018 | -98.58M |
| March 31, 2018 | 27.03M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-125.52M
Minimum
Jun 2022
179.24M
Maximum
Jun 2020
57.79M
Average
72.32M
Median
Cash from Operations (Quarterly) Benchmarks
| Eli Lilly and Co | 1.466B |
| Amphastar Pharmaceuticals Inc | 69.11M |
| Nutriband Inc | -1.544M |
| NovaBay Pharmaceuticals Inc | -0.578M |
| Palatin Technologies Inc | -8.607M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -6.465M |
| Cash from Financing (Quarterly) | -35.09M |
| Free Cash Flow | 176.08M |
| Free Cash Flow Per Share (Quarterly) | 0.0884 |
| Free Cash Flow to Equity (Quarterly) | 47.37M |
| Free Cash Flow to Firm (Quarterly) | 82.27M |
| Free Cash Flow Yield | 8.35% |